AI Article Synopsis

  • Targeting metabolic pathways, specifically glycolysis, is being explored as a potential new strategy for treating migraines, as metabolism plays a crucial role in migraine development.
  • In an experimental rat model, researchers observed significant changes in glycolytic enzyme expression and found that the glycolysis inhibitor 2-Deoxy-D-glucose (2-DG) could alleviate migraine symptoms and reduce inflammation.
  • The study concluded that inhibiting glycolysis not only lessened migraine-like symptoms but also impacted microglial activation and neuroinflammatory processes linked to migraines.

Article Abstract

Background: Targeting metabolic pathways has emerged as a new migraine treatment strategy as researchers realize the critical role metabolism plays in migraine. Activated inflammatory cells undergo metabolic reprogramming and rely on glycolysis to function. The objective of this study was to investigate the glycolysis changes in the experimental model of migraine and the effect of glycolysis inhibitor 2-Deoxy-D-glucose (2-DG) in the pathophysiology of migraine.

Methods: We used a rat model of migraine that triggered migraine attacks by applying inflammatory soup (IS) to the dura and examined changes in glycolysis. 2-DG was used to inhibit glycolysis, and the effects of 2-DG on mechanical ectopic pain, microglial cell activation, calcitonin gene-related peptides (CGRP), c-Fos, and inflammatory factors induced by inflammatory soup were observed. LPS stimulated BV2 cells to establish a model to observe the effects of 2-DG on brain-derived neurotrophic factor (BDNF) after microglia activation.

Results: In the experimental model of migraine, key enzymes involved in glycolysis such as phosphofructokinase platelet (PFKP), hexokinase (HK2), hypoxia inducible factor-1α (HIF-1α), lactate dehydrogenase (LDH) and pyruvate kinase (PKM2) were expressed in the medullary dorsal horn. While the expression of electronic respiratory transport chain complex IV (COXIV) decreased. There were no significant changes in glucose 6-phosphate dehydrogenase (G6PD), a key enzyme in the pentose phosphate pathway. The glycolysis inhibitor 2-DG alleviated migraine-like symptoms in an experimental model of migraine, reduced the release of proinflammatory cytokines caused by microglia activation, and decreased the expression of CGRP and c-Fos. Further experiments demonstrated that glycolysis inhibition can reduce the release of Iba-1/proBDNF/BDNF and inhibit the activation of microglia.

Conclusion: The migraine rat model showed enhanced glycolysis. This study suggests that glycolytic inhibitor 2-DG is an effective strategy for alleviating migraine-like symptoms. Glycolysis inhibition may be a new target for migraine treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117646PMC
http://dx.doi.org/10.3389/fneur.2023.1115318DOI Listing

Publication Analysis

Top Keywords

model migraine
20
experimental model
16
migraine
10
glycolysis
10
inflammatory factors
8
migraine treatment
8
glycolysis inhibitor
8
rat model
8
inflammatory soup
8
effects 2-dg
8

Similar Publications

Seasonal Variations in Triptan Prescription in Japan: A Nationwide Time-Series Analysis.

Brain Behav

December 2024

Department of Medical Affairs, Otsuka Pharmaceutical Co. Ltd, Tokyo, Japan.

Objective: This study aimed to investigate seasonal differences in migraine onset in Japan and associated trends in the prescription of triptan.

Background: The relationship between seasonal changes and the onset of migraine remains largely unknown.

Methods: We combined the large-scale medical claims data in Japan with city-level meteorological data presented by the Japan Weather Association.

View Article and Find Full Text PDF

Purpose: This study aims to investigate whether artificial intelligence can improve the diagnostic accuracy of vertigo related diseases.

Experimental Design: Based on the clinical guidelines, clinical symptoms and laboratory test results were extracted from electronic medical records as variables. These variables were then input into a machine learning diagnostic model for classification and diagnosis.

View Article and Find Full Text PDF

Background: Migraine is a disabling neurovascular disorder often associated with comorbidities such as mental health disorders, cardiovascular diseases, and metabolic syndromes. While certain dietary triggers have been identified, the impact of overall diet quality on migraine severity and frequency is not well understood. This study aimed to evaluate the association between diet quality, lifestyle factors, and the Healthy Eating Index (HEI) with migraine severity and frequency.

View Article and Find Full Text PDF

Background: Migraine is a painful neurological syndrome characterized by attacks of throbbing headache, of moderate to severe intensity, which is associated with photo- and phono- sensitivity as well as nausea and vomiting. It affects about 15% of the world's population being 2-3 times more prevalent in females. The calcitonin gene-related peptide (CGRP) is a key mediator in the pathophysiology of migraine, and a significant advance in the field has been the development of anti-CGRP therapies.

View Article and Find Full Text PDF

Background: The total burden of migraine includes not only the episodes with headache pain but extends throughout the interictal periods. Interictal symptoms and associated psychological responses may profoundly impact well-being and drive treatment-seeking behavior.

Methods: A cross-sectional online survey was conducted with participants aged ≥ 18 years, 250 with episodic migraine (EM) and 250 with chronic migraine (CM), having ≥ 4 monthly migraine headache days.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!